ATM and familial pancreatic carcinoma: Heterozygous carriers of ATM PVs are at increased risk of several types of cancer, including pancreatic cancer, and it is estimated that up to 3% of high-risk individuals who develop pancreatic cancer harbor an ATM PV [25,35,59,60].